Skip to content

US · QSI · BIOTECHNOLOGY

Quantum-Si incorporated (QSI) intrinsic value and stock valuation

$0.92as of 2026-11-21 · Mkt cap 161.11M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Quantum-Si incorporated DCF and intrinsic value

InvestorsCraft values QSI with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from QSI’s statements →

Quantum-Si incorporated Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Biotechnology Branford, CT 06405 quantum-si.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$2.44M
20192025
Net income
-$-101.34M
20192025
Free cash flow
-$-97.23M
20192025
Total equity
$220.2M+43.6% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$2.44M$3.06M$1.08M$0.00$0.00
Operating income-$-97.36M-$-108.58M-$-111.17M-$-123.84M-$-96.91M
Net income-$-101.34M-$-101.01M-$-95.96M-$-132.44M-$-94.99M
EPSd-$-512.44K-$-705.38K-$-679.12K-$-951.03K-$-1.19M
Operating cash flow-$-94.72M-$-87.8M-$-94.04M-$-90.56M-$-66.81M
Capital expenditure-$-2.52M-$-4.58M-$-5.27M-$-10.74M-$-5.76M
Free cash flow-$-97.23M-$-92.38M-$-99.31M-$-101.3M-$-72.58M
Total assets$245.6M$247.9M$298.3M$391.5M$503.2M
Total debt$4.17M$13M$15.3M$17.5M$8.08M
Net debt-$-17.47M-$-36.29M-$-118.56M-$-66.87M-$-27.71M
Total equity$220.2M$215.4M$271.6M$358.7M$477M
Cash and short-term investments$162.9M$209.6M$257.7M$351.3M$471.3M
Income statement
20252024202320222021
Revenue$2.44M$3.06M$1.08M$0.00$0.00
Cost of revenue$1.28M$1.46M$590K$0.00$0.00
Gross profit$1.15M$1.6M$490K$0.00$0.00
Research and development expenses$53.8M$59.6M$67M$72.1M$46.6M
Selling, general and administrative expenses$44.8M$50.5M$44.6M$42.3M$50.3M
Other expenses$0.00$0.00$0.00$9.48M$0.00
Operating expenses$98.5M$110.2M$111.7M$123.8M$96.9M
Cost and expenses$99.8M$111.6M$112.3M$123.8M$96.9M
Interest income$8.96M$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$10K
Depreciation and amortization$4.45M$4.6M$4.16M$2.58M$1.04M
Ebitda-$-92.91M-$-96.35M-$-91.8M-$-111.77M-$-93.94M
Operating income-$-97.36M-$-108.58M-$-111.17M-$-123.84M-$-96.91M
Total other income/expenses, net-$-3.92M$7.62M$15.2M-$-8.6M$1.92M
Income before tax-$-101.28M-$-100.95M-$-95.96M-$-132.44M-$-94.99M
Income tax expense$60K$60K$0.00$0.00$0.00
Net income-$-101.34M-$-101.01M-$-95.96M-$-132.44M-$-94.99M
Weighted average shares outstanding$197.8M$143.2M$141.3M$139.3M$79.6M
Weighted average diluted shares outstanding$197.8M$143.2M$141.3M$139.3M$79.6M
Balance sheet
20252024202320222021
Cash and short-term investments$162.9M$209.6M$257.7M$351.3M$471.3M
Net receivables$560K$1.33M$370K$0.00$0.00
Inventory$3.2M$4.07M$3.94M$0.00$0.00
Total current assets$175.9M$218M$266.3M$358.2M$477.2M
Property, plant and equipment, net$16.7M$29.1M$30.7M$32.6M$15.9M
Goodwill and intangible assets$0.00$0.00$530K$0.00$9.48M
Long-term investments$52.9M$0.00$0.00$0.00$0.00
Total non-current assets$69.8M$29.9M$31.9M$33.3M$26.1M
Total assets$245.6M$247.9M$298.3M$391.5M$503.2M
Accounts payable$1.62M$1.93M$1.77M$3.9M$3.39M
Short-term debt$1.84M$3.7M$1.57M$1.37M$860K
Deferred revenue$3.49M$0.00$0.00$0.00$0.00
Total current liabilities$23M$18.2M$11.6M$15.7M$11.5M
Long-term debt$2.32M$9.25M$13.7M$16.1M$7.22M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$2.36M$14.3M$15M$17.1M$14.7M
Capital lease obligations$4.17M$13M$15.3M$17.5M$8.08M
Total liabilities$25.4M$32.5M$26.6M$32.8M$26.2M
Common stock$20K$20K$10K$10K$10K
Retained earnings-$-697.98M-$-596.64M-$-495.63M-$-399.67M-$-267.23M
Accumulated other comprehensive income (loss)-$-10K$40K$0.00$0.00$0.00
Total equity$220.2M$215.4M$271.6M$358.7M$477M
Total investments$194.1M$160.4M$123.9M$267M$435.5M
Total debt$4.17M$13M$15.3M$17.5M$8.08M
Net debt-$-17.47M-$-36.29M-$-118.56M-$-66.87M-$-27.71M
Cash flow statement
20252024202320222021
Net income-$-101.34M-$-101.01M-$-95.96M-$-132.44M-$-94.99M
Depreciation and amortization$4.45M$4.6M$4.16M$2.58M$1.04M
Stock-based compensation$10.8M$8.89M$8.52M$11.2M$24.9M
Change in working capital-$-4.58M$4.64M-$-3.19M$3.05M$1.47M
Accounts receivable$630K-$-1.09M-$-370K$0.00$0.00
Inventory-$-2.01M$4.34M$290K$0.00$0.00
Accounts payable-$-340K$390K-$-1.22M$720K$710K
Net cash provided by operating activities-$-94.72M-$-87.8M-$-94.04M-$-90.56M-$-66.81M
Investments in property, plant and equipment-$-2.52M-$-4.58M-$-4.51M-$-10.74M-$-5.76M
Acquisitions, net$0.00$0.00$0.00$0.00-$-4.63M
Net cash used for investing activities-$-28.32M-$-32.67M$143.4M$137.2M-$-450.94M
Common stock issued$95.4M$34.8M$0.00$2.76M$512.8M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$95.4M$35.9M$150K$1.91M$516.6M
Net change in cash-$-27.6M-$-84.62M$49.5M$48.5M-$-1.12M
Cash at end of period$21.6M$49.2M$133.9M$84.3M$35.8M
Operating cash flow-$-94.72M-$-87.8M-$-94.04M-$-90.56M-$-66.81M
Capital expenditure-$-2.52M-$-4.58M-$-5.27M-$-10.74M-$-5.76M
Free cash flow-$-97.23M-$-92.38M-$-99.31M-$-101.3M-$-72.58M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Quantum-Si incorporated

        Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.

        CEO
        Jeffrey Alan Hawkins
        Employees
        145
        Beta
        3.20

        Explore

        Frequently asked questions

        What is the intrinsic value of Quantum-Si incorporated (QSI)?

        InvestorsCraft does not currently publish an intrinsic value for QSI. How the IC value is calculated.

        Is QSI undervalued?

        InvestorsCraft does not publish an undervaluation signal for QSI at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.